Signaling Pathways - MLK3 - Insulin and Insulin-like Receptors - Vitamin D receptors (VDRs) - Synthases/Synthetases
清除全部
-
B4877 URMC-099Target: MLK3Summary: MLK3抑制剂 -
B7070 Triacsin CTarget: Synthases/SynthetasesSummary: 酰基辅酶A合成酶抑制剂 -
B2140 Calcifediol中文名: 骨化二醇Target: Vitamin D receptors (VDRs)Summary: 维生素D3的主要循环形式 -
B2091 Doxercalciferol1 Citation中文名: 度骨化醇Target: Vitamin D receptors (VDRs)Summary: 维生素D受体激活剂 -
B1472 Mizoribine中文名: 咪唑立宾Target: Synthases/SynthetasesSummary: DNA/RNA合成抑制剂 -
A8463 Lithocholic Acid中文名: 石胆酸Target: Farnesoid X receptors (FXRs)|Vitamin D receptors (VDRs)|Pregnane X receptor(PXR)Summary: 维生素D受体PXR和FXR的激活剂 -
A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂 -
A5588 Oligomycin A1 Citation中文名: 寡霉素ATarget: Synthases/SynthetasesSummary: 线粒体ATP合成酶抑制剂 -
A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂 -
A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂